BioStem Technologies to Lead Discussions at Wound Care Symposium

BioStem Technologies Takes Center Stage at SAWC Spring Meeting

BioStem Technologies, Inc. (OTC: BSEM) is preparing to make a significant impact at the upcoming Symposium for Advanced Wound Care (SAWC) Spring meeting, where it will proudly co-exhibit with its strategic partner Venture Medical, LLC. This collaboration underscores their joint commitment to innovation in chronic wound care management.

The SAWC is recognized as a leading platform for educating healthcare professionals focused on treating patients with chronic wounds. During this event, BioStem will not only highlight its proprietary BioREtain® technology but will also feature three scientific posters that affirm the efficacy of its advanced allograft portfolio.

Collaborative Innovation in Wound Care

By co-exhibiting with Venture Medical, BioStem aims to spotlight the combined strengths of its leading placental allograft alongside the Venture OneView™ platform. This state-of-the-art platform is designed to simplify the management of patients who require skin substitutes for chronic wound treatment. “Our premier products, AmnioWrap2® and Vendaje AC®, are primarily available through Venture Medical,” shared Jason Matuszewski, CEO of BioStem. “This partnership provides healthcare providers with tools to enhance patient care from insurance verification through treatment, ultimately streamlining the entire care process.”

SAWC Booth Schedule Overview

The BioStem and Venture Medical booth will feature designated times for attendees to interact with key industry stakeholders. Important discussions will include the emerging reimbursement landscape and building a successful mobile wound care practice. Also highlighted will be compelling data supporting the advantages of BioStem’s proprietary BioREtain® technology and how the Venture OneView™ platform benefits providers.

Highlighting Critical Topics

Friday's schedule includes a sponsored breakfast symposium titled Healing Under Pressure: Advancements in Skin Substitutes for Pressure Ulcer Treatment. This critical discussion will address the necessity of advanced wound care technologies in improving outcomes for patients with non-healing chronic wounds. Topics will cover the latest real-world clinical evidence, data collection efforts, practice management strategies, and legislative actions needed to enhance access to treatment.

Scientific Contributions and Insights

BioStem is excited to announce the display of three accepted scientific posters during the conference, each showcasing valuable clinical and scientific research regarding BioStem’s products. These include:

• Retrospective Analysis of Complicated Diabetic Foot Ulcers: A Comparison of Retention-Processed Placental Membranes and Standard of Care
• A Case Series for Managing Complicated Diabetic Foot Wounds
• Preservation of Key Molecular and Stromal Components via Retention Processing

The data presented in these posters aims to demonstrate the favorable outcomes achieved with BioStem’s BioREtain® technology compared to competitive products. Dr. Wendy Weston, Vice President of Research and Development at BioStem, remarked, “We’re committed to investing in evidence that supports the efficacy of our technology.”

About BioREtain® Technology

BioStem’s BioREtain® method is a proprietary processing technique that retains the essential properties of perinatal tissues while preserving the structure and matrix crucial for effective wound treatment. This patented process is gentle and minimally invasive, ensuring the integrity of amniotic tissue, which is vital for optimal healing outcomes.

Fundamentally, BioStem Technologies stands as a beacon of hope in wound care innovation. Each placental allograft is processed at their FDA registered and AATB accredited facility, embodying their commitment to quality and safety.

Connection and Collaboration

BioStem invites the healthcare community to join their distribution list and engage through their social media channels to stay updated on the latest developments. By fostering a community around wound care, BioStem aims to improve practices and outcomes for patients worldwide.

Frequently Asked Questions

What is the focus of BioStem Technologies?

BioStem Technologies specializes in developing placental-derived products for advanced wound care.

What is the BioREtain® technology?

BioREtain® is a proprietary processing method that preserves the natural properties of perinatal tissues for enhanced wound healing.

Where will the symposium take place?

The SAWC Spring meeting will be held in Dallas, Texas.

How can I learn more about BioStem products?

You can explore BioStem’s offerings by visiting their website or contacting their support team directly.

What partnership does BioStem have at the symposium?

BioStem is co-exhibiting with Venture Medical, emphasizing their collaborative efforts in wound care solutions.

About The Author

Hi there I'm 38-year-old author and financial consultant Owen Jenkins. Having worked in the financial sector for more than ten years, I am well-versed in the subtleties and complexity that mold our financial environment. Following a degree in finance, I worked in a number of financial institutions honing my abilities in market analysis, financial planning, and investment strategies.

My love is teaching others about investing and personal finance. My goal in writing many books and articles has been to demystify financial ideas and give readers the information they need to make wise financial decisions. I write with a direct, useful style that emphasizes doable suggestions for daily living.

Along with writing, I lead webinars and seminars where I impart knowledge on how to successfully negotiate the financial world. I also write for financial journals and show up as a guest expert on financial news programs a lot. Whether they are new to investing or want to improve their approach, my mission is to enable people to take charge of their financial futures.

Beyond work, I like to hike, play the guitar, and spend time with my family. I think that balance is crucial and want to encourage people to strike a balance between their financial aspirations and their hobbies. I want to help people succeed and achieve financial security through my work, so having a good influence.

Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.